Related Experiment Video
Updated: Jun 21, 2026

Engineered 3D Silk-collagen-based Model of Polarized Neural Tissue
Published on: October 23, 2015
The design and molecular modeling of CNS drugs
1Cerebrus, Winnersh, Berkshire RG41 5UA, UK. A.George@cerebrus.co.uk
Abstract:
The medical need for new drugs to treat CNS disorders and their commercial potential is not in question, however, CNS drugs may require different pharmacokinetic and pharmacological profiles to peripherally acting compounds. The role of molecular modeling in both identifying and rationalizing the design of CNS compounds has led to the development of a powerful array of techniques. This review addresses a number of prominent issues for CNS drug discovery and describes highlights that provide some insights into the use of molecular modeling to define and enhance the pharmacological profile of novel compounds.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drug Discovery: Overview
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Neurochemical Transmission: Sites of Drug Action

